PH13966A - Piperazinyl quinazoline derivatives as antihypertensives - Google Patents

Piperazinyl quinazoline derivatives as antihypertensives

Info

Publication number
PH13966A
PH13966A PH21726A PH21726A PH13966A PH 13966 A PH13966 A PH 13966A PH 21726 A PH21726 A PH 21726A PH 21726 A PH21726 A PH 21726A PH 13966 A PH13966 A PH 13966A
Authority
PH
Philippines
Prior art keywords
antihypertensives
quinazoline derivatives
piperazinyl quinazoline
piperazinyl
derivatives
Prior art date
Application number
PH21726A
Other languages
English (en)
Inventor
S Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH13966A publication Critical patent/PH13966A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PH21726A 1977-11-05 1978-10-24 Piperazinyl quinazoline derivatives as antihypertensives PH13966A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4612877 1977-11-05

Publications (1)

Publication Number Publication Date
PH13966A true PH13966A (en) 1980-11-12

Family

ID=10439957

Family Applications (1)

Application Number Title Priority Date Filing Date
PH21726A PH13966A (en) 1977-11-05 1978-10-24 Piperazinyl quinazoline derivatives as antihypertensives

Country Status (36)

Country Link
JP (1) JPS5498792A (de)
AR (2) AR219562A1 (de)
AT (1) AT365186B (de)
AU (1) AU509329B2 (de)
BE (1) BE871771A (de)
CA (1) CA1088059A (de)
CH (1) CH643255A5 (de)
CS (2) CS207671B2 (de)
DD (1) DD139850A5 (de)
DE (1) DE2847623C2 (de)
DK (1) DK154082C (de)
EG (1) EG13594A (de)
ES (2) ES474805A1 (de)
FI (1) FI64366C (de)
FR (1) FR2407929A1 (de)
GR (1) GR81514B (de)
HK (1) HK94284A (de)
HU (1) HU176306B (de)
IE (1) IE47888B1 (de)
IL (1) IL55857A (de)
IN (1) IN148828B (de)
IT (1) IT1100919B (de)
KE (1) KE3350A (de)
LU (2) LU80470A1 (de)
MY (1) MY8500286A (de)
NL (2) NL174549C (de)
NO (1) NO150158C (de)
NZ (1) NZ188813A (de)
PH (1) PH13966A (de)
PL (2) PL119419B1 (de)
PT (1) PT68735A (de)
SE (1) SE437518B (de)
SU (1) SU816403A3 (de)
UA (1) UA8324A1 (de)
YU (2) YU40204B (de)
ZA (1) ZA786184B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002644A1 (en) * 1984-11-01 1986-05-09 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
WO1985004658A1 (en) * 1984-04-04 1985-10-24 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepine derivatives and their preparation
WO1985002617A1 (en) * 1983-12-14 1985-06-20 Takeda Chemical Industries. Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
PT849266E (pt) * 1996-12-20 2007-03-30 Heumann Pcs Gmbh Nova forma polimorfa de mesilato de doxazosina (forma iii)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
TW448155B (en) * 1999-03-29 2001-08-01 Dev Center Biotechnology Method for producing amide compounds and quinazolin derivatives
EP1403263B1 (de) * 2002-09-27 2005-06-22 Council of Scientific and Industrial Research Verfahren zur Herstellung von N-2,3-Dihydrobenzo[1,4]dioxin-2-carbosäure-piperazinamid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
DK154082C (da) 1989-02-27
NL7810909A (nl) 1979-05-08
YU255378A (en) 1983-06-30
AR223015A1 (es) 1981-07-15
FR2407929B1 (de) 1981-02-27
CS207671B2 (en) 1981-08-31
FR2407929A1 (fr) 1979-06-01
FI64366C (fi) 1983-11-10
NL174549C (nl) 1984-07-02
IL55857A0 (en) 1979-01-31
ES8308559A1 (es) 1980-07-16
SE7811382L (sv) 1979-05-06
YU40204B (en) 1985-08-31
NL174549B (nl) 1984-02-01
AU509329B2 (en) 1980-05-08
YU38683A (en) 1983-06-30
ES480121A0 (es) 1980-07-16
MY8500286A (en) 1985-12-31
NO150158B (no) 1984-05-21
NZ188813A (en) 1980-10-08
PL119419B1 (en) 1981-12-31
AU4132278A (en) 1979-05-17
JPS5498792A (en) 1979-08-03
UA8324A1 (uk) 1996-03-29
IL55857A (en) 1982-07-30
FI783347A (fi) 1979-05-06
EG13594A (en) 1982-03-31
ATA784378A (de) 1981-05-15
CS354491A3 (en) 1992-06-17
YU40419B (en) 1985-12-31
NO783705L (no) 1979-05-08
NL930062I1 (nl) 1993-09-01
DE2847623C2 (de) 1983-06-01
FI64366B (fi) 1983-07-29
GR81514B (de) 1984-12-11
SE437518B (sv) 1985-03-04
DD139850A5 (de) 1980-01-23
KE3350A (en) 1983-12-16
AT365186B (de) 1981-12-28
IN148828B (de) 1981-06-27
CH643255A5 (en) 1984-05-30
IE782179L (en) 1979-05-05
LU80470A1 (fr) 1980-06-05
AR219562A1 (es) 1980-08-29
SU816403A3 (ru) 1981-03-23
IT7829434A0 (it) 1978-11-03
JPS5625233B2 (de) 1981-06-11
CA1088059A (en) 1980-10-21
HU176306B (en) 1981-01-28
DK428678A (da) 1979-05-06
ZA786184B (en) 1979-10-31
ES474805A1 (es) 1980-01-16
NL930062I2 (nl) 1993-11-16
IT1100919B (it) 1985-09-28
PT68735A (en) 1978-12-01
PL119586B1 (en) 1982-01-30
IE47888B1 (en) 1984-07-11
PL210681A1 (de) 1979-11-05
DK154082B (da) 1988-10-10
DE2847623A1 (de) 1979-05-23
HK94284A (en) 1984-12-07
NO150158C (no) 1984-08-29
LU88331I2 (fr) 1994-05-04
BE871771A (fr) 1979-05-03

Similar Documents

Publication Publication Date Title
AU518108B2 (en) Quinazoline compounds
GB2065653B (en) Anti-cancer quinazoline derivatives
AU506317B2 (en) Quinazoline derivatives
AU506410B2 (en) Quinazoline derivatives
PH13966A (en) Piperazinyl quinazoline derivatives as antihypertensives
ZA805920B (en) Quinazoline derivatives
FI780918A (fi) Kinazolin-derivat
AU509348B2 (en) Quinazoline derivatives
ZA80557B (en) Quinazoline antihypertensives
ZA772728B (en) Quinazoline derivatives
AU507828B2 (en) Quinazoline derivatives
IL54336A0 (en) Novel pyrimidine derivatives
IL55492A0 (en) The preparation of certain quinazoline derivatives
JPS5289682A (en) Quinazoline derivatives
SG60982G (en) Pyrimidine derivatives
ZA804015B (en) Quinazoline derivatives
GB2001069B (en) Pyrimidine derivatives
JPS5466691A (en) Novel quinazoline derivative and manufacture
GB2049683B (en) Quinazoline antihypertensives
GB2041373B (en) Quinazoline antihypertensives
ZA807909B (en) Anti-cancer quinazoline derivatives
AU2849677A (en) Quinazoline derivatives
ZA773939B (en) Quinazoline derivatives
GB2003858B (en) Pyrazolo(1,5c)quinazoline derivatives and related compounds
IE780583L (en) Quinazoline derivatives

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 16